Cytogel Pharma is a pharmaceutical company based in Darien, Connecticut, specializing in the development of novel therapeutics for post-surgical pain. With a focus on drug delivery technology and hydrogel technology, Cytogel Pharma aims to provide innovative solutions for pain management.
Driven by a mission to improve patient outcomes, Cytogel Pharma's pipeline includes CYT-1010, a next-generation endomorphin, which utilizes a novel mechanism of action to target post-surgical pain. Collaborating with partners and collaborators, the company strives to advance its research and development efforts in the field of pain management.
Generated from the website